title: Guanosine-induced synaptogenesis in the adult brain in vivo.
abstract: Astrocytes release factors like cholesterol, apoE, and pleiotropic molecules that influence synaptogenesis in the central nervous system. In vitro studies have shown that guanosine elicits the production and further release of these synaptogenic factors. To demonstrate that such astrocytic factors are synaptogenic in vivo, osmotic pumps were implanted in primary visual cortex (VC) of Sprague-Dawley rats to deliver guanosine. Simultaneous injection of dextran amine as an anterograde tracer at the same site where the osmotic pumps were implanted enabled the morphology of the fibers emerging from the VC to be visualized as well. The guanosine-treated efferent connections from these animals showed a significant increase in the number and size of synaptic boutons along the efferent fibers when compared with controls. A similar increase in the number and size of synaptic boutons was also detected when the cortico-cortical connection to the lateral secondary visual area was studied in more detail. The ensuing morphological changes to the synapses did not show a clear preference for any particular type or site of the axonal branches that integrates this cortical connection. Moreover, the distribution of boutons along the fibers was clearly stochastic according to their size. Thus, guanosine administration appears to open up the possibility of manipulating connections to compensate for total or partial denervation.
authors: Department of Neurosciences, University of the Basque Country, Bizkaia, Spain.
authors: Inmaculada
authors: I
authors: Gerrikagoitia
authors: Luis
authors: L
authors: Martínez-Millán
mesh_terms: D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D001921:Brain / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D001927:Brain Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D004396:Coloring Agents / Q000378:metabolism; D003911:Dextrans / Q000378:metabolism; D006151:Guanosine / Q000494:pharmacology* / Q000627:therapeutic use; D015918:Infusion Pumps, Implantable; D008297:Male; D009416:Nerve Regeneration / Q000187:drug effects* / Q000502:physiology; D056347:Neuroanatomical Tract-Tracing Techniques / Q000379:methods; D055495:Neurogenesis / Q000187:drug effects* / Q000502:physiology; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology; D017729:Presynaptic Terminals / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D013194:Staining and Labeling; D013569:Synapses / Q000187:drug effects* / Q000502:physiology; D014793:Visual Cortex / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D014795:Visual Pathways / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
chemical_list: D004396:Coloring Agents; D003911:Dextrans; D006151:Guanosine